Slate Path Capital Portfolio holdings
Slate Path Capital runs hedge funds that go long and short on stocks around the world, with sizeable positions in other assets too. The firm was established in 2012 and is owned by David Greenspan and JADES GP, a company in which Greenspan is the principal owner. Its stock picking rests on company research, and it aims for long-term growth adjusted for risk. Its two main funds use significant leverage and concentrated positions, and the firm can also trade digital assets such as Bitcoin and Ethereum. One group of its funds avoids long positions in fossil fuel assets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walgreens Boots Alliance
WBA
|
+$147M |
| 2 |
ZNGA
Zynga
ZNGA
|
+$68.3M |
| 3 |
ANDV
Andeavor
ANDV
|
+$65M |
| 4 |
IPXL
Impax Laboratories
IPXL
|
+$59.7M |
| 5 |
Marathon Petroleum
MPC
|
+$46.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$93.8M |
| 2 |
Allegion
ALLE
|
+$93.5M |
| 3 |
ENDP
Endo International
ENDP
|
+$77.7M |
| 4 |
Intuitive Surgical
ISRG
|
+$55.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.62% |
| 2 | Communication Services | 16.75% |
| 3 | Healthcare | 16.5% |
| 4 | Energy | 8.35% |
| 5 | Materials | 5.03% |
Similar funds
Slate Path Capital's Q3 2014 Portfolio in Review
As of Q3 2014, Slate Path Capital held 26 positions worth $2.22B, down 38% from $3.58B the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Slate Path Capital deployed $165M of net new capital in Q3 2014, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Walgreens Boots Alliance: 2,245,000 shares worth $133M.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 67% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Intuitive Surgical, an estimated $55.4M trimmed.
- Slate Path Capital's largest Q3 2014 buy was Walgreens Boots Alliance: 2,245,000 shares worth $133M.
- Slate Path Capital added most to Marathon Petroleum in Q3 2014, an estimated $46.3M increase.
- Slate Path Capital's biggest Q3 2014 reduction was Intuitive Surgical, cutting an estimated $55.4M.
- Slate Path Capital fully exited Trip.com Group in Q3 2014, selling an estimated $93.8M.
- Slate Path Capital's ten largest holdings make up 79% of its $2.22B portfolio in Q3 2014.
- Slate Path Capital opened 8 new positions and closed 6 in Q3 2014.
- Slate Path Capital's portfolio value fell 38% quarter-over-quarter to $2.22B.
Based on Slate Path Capital's 13F filing for Q3 2014, filed 14 Nov 2014.